Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil versus placebo before exercise challenge in chronic fatigue syndrome
ACTRN12616000487415Phase 4Recruiting
- Sponsor
- University of New South Wales
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of modafinil in myalgic encephalomyelitis (ME) (2 arms), sponsored by University of New South Wales. Primary endpoints: Rating of perceived exertion and Fatigue and Energy Scale global score. Started Apr 2017; status: recruiting.
02
Drugs
modafinil
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on ACTRN12616000487415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000487415.